EX-23.3 2 g083467_ex23-3.htm EXHIBIT 23.3

Exhibit 23.3

 

Consent of Independent Registered Public Accounting Firm

 

To the Board of Directors 

Lipella Pharmaceuticals Inc. 

Pittsburgh, PA

 

We hereby consent to the incorporation by reference in this Post-Effective Amendment No. 1 to the Registration Statement of Lipella Pharmaceuticals Inc. on Form S-1 (Registration No. 333-266397) of our report dated March 31, 2023, relating to the financial statements of Lipella Pharmaceuticals Inc., which appears in the Annual Report on Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.

 

We also consent to the reference to us under the caption “Experts” in that Registration Statement.

 

/s/ Urish Popeck & Co., LLC 

Pittsburgh, PA

 

April 3, 2023